Andra AP fonden Has $14.53 Million Position in Danaher Corporation $DHR

Andra AP fonden lifted its stake in Danaher Corporation (NYSE:DHR) by 648.7% in the first quarter, HoldingsChannel reports. The institutional investor owned 76,642 shares of the conglomerate’s stock after buying an additional 66,405 shares during the quarter. Andra AP fonden’s holdings in Danaher were worth $14,531,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Main Street Group LTD acquired a new stake in shares of Danaher in the first quarter valued at approximately $25,000. JPL Wealth Management LLC acquired a new position in Danaher during the 3rd quarter worth $25,000. Elevated Capital Advisors LLC bought a new position in Danaher in the 4th quarter valued at $26,000. WFA of San Diego LLC bought a new position in Danaher in the 2nd quarter valued at $26,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in shares of Danaher in the 4th quarter valued at $27,000. Institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently commented on DHR. Citigroup began coverage on shares of Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target for the company. Wells Fargo & Company reduced their price objective on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 22nd. Wall Street Zen cut shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Rothschild & Co Redburn set a $205.00 price target on Danaher in a research note on Friday, April 17th. Finally, Guggenheim reduced their price target on Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $231.64.

Danaher Stock Down 11.0%

Shares of DHR stock opened at $179.01 on Wednesday. The company has a market capitalization of $126.70 billion, a price-to-earnings ratio of 34.62, a P/E/G ratio of 2.48 and a beta of 0.79. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The firm has a fifty day moving average of $184.22 and a 200-day moving average of $197.69. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, July 21st. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.84 by $0.10. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.11 billion. During the same period last year, the company earned $0.77 earnings per share. Danaher’s quarterly revenue was up 5.5% on a year-over-year basis. As a group, equities research analysts predict that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. Danaher’s payout ratio is currently 30.95%.

Key Headlines Impacting Danaher

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher posted Q2 adjusted EPS of $1.94, above the $1.84 consensus, and revenue of about $6.26 billion to $6.3 billion, also ahead of estimates. Danaher Reports Second Quarter 2026 Results
• Positive Sentiment: Management raised full-year adjusted EPS guidance, showing confidence in profitability despite the softer sales backdrop. Danaher Corp (DHR) Q2 2026 Earnings Call Highlights
• Neutral Sentiment: Life Sciences was a bright spot, with stronger sales growth, but bioprocessing revenue came in weaker than expected and was cited as a drag on sentiment. Reuters: Danaher’s revenue outlook cut, biotech miss overshadow profit forecast raise
• Negative Sentiment: Investors reacted negatively to the reduced core revenue growth outlook and cautious near-term guidance, which outweighed the earnings beat and led to the stock decline. Danaher stock slips despite Q2 earnings beat, raised guidance
• Negative Sentiment: Analysts also highlighted “surprisingly soft” bioprocessing sales, reinforcing concerns that growth may slow more than expected. Danaher Plummets After One Segment Comes In ‘Surprisingly Soft’

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.